#41 Anti-Seizure Medication Management: Adherence & Statistics - Samuel Terman - University of Michigan, USA

Samuel Terman is an epileptologist and researcher from the University of Michigan, US, and specialises in caring for people with seizures and epilepsy. In his research Samuel focuses on optimising the delivery of medical care for patients with epilepsy, through medication decisions, hospital utilisation and readmissions, and inpatient seizure monitoring quality of care.

• Content

  Topics:

  • Factors associated with 30-day readmission for patients hospitalized for seizures;

  • Polypharmacy composition and patient -and provider-related variation in patients with epilepsy;

  • First, do no net harm;

  • Disability in people with epilepsy: A nationally representative cross-sectional study

• About Samuel

  Samuel Terman is an epileptologist and researcher from the University of Michigan, US who specialises in helping people affected by seizures and epilepsy. Samuel tells us about his research into adherence to medications, polypharmacy, deprescribing, and the high rate of multiple disabilities amongst those with epilepsy. Samuel’s work focuses on optimising the delivery of medical care for patients with epilepsy, through medication decisions, hospital utilisation and readmissions, and inpatient seizure monitoring quality of care.

• Links

  LinkedIn | University of Michigan

  Neurology: Factors associated with 30-day readmission for patients hospitalized for seizures

  Epilepsy & Behavior: Polypharmacy composition and patient -and provider-related variation in patients with epilepsy

  Epilepsy & Behavior: Deprescribing in Epilepsy: “First do no net harm”:

  Epilepsy & Behavior: Disability in people with epilepsy: A nationally representative cross-sectional study

Join me and share on social

---

Other episodes:

---